Gaffigan admitted to having trepidation to use the medication, a brand name for tirzepatide, after tipping the scales at 270 ...

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

The use of weight loss drugs without doctor's supervision is not advisable and can lead to serious side effects and ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Global diabetes rates have surged, particularly in low-resource areas, revealing critical gaps in treatment access and ...

There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight ...

GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

Artemis Bayandor from Illinois in the US lost over a stone after starting to take game-changing weight-loss jabs, but like ...

Jim Gaffigan has revealed using a weight-loss drug gave him a "better life". The comedian wants to challenge the stigma ...

Obesity is a chronic condition and a key risk factor for a range of other health issues, including type 2 diabetes. In a ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...